Incorporating life expectancy in glaucoma care

Eye

Volumn 25, Issue 12, 2011, Pages 1575-1580

  Wesselink, C ^a   Stoutenbeek, R ^a   Jansonius, N M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ageing; perimetry; glaucoma; healthy ageing; rate of progression

Indexed keywords

AGE; AGED; ARTICLE; CLINICAL DECISION MAKING; DISEASE COURSE; FOLLOW UP; GLAUCOMA; HUMAN; LIFE EXPECTANCY; MALE; PERIMETRY; SURVIVAL RATE; SURVIVAL TIME; VISUAL IMPAIRMENT;

EID: 83455186707     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.213     Document Type: Article

References (30)

1. Ang GS, Eke T. Lifetime visual prognosis for patients with primary open-angle glaucoma. Eye (Lond) 2007; 21: 604-608. (Pubitemid 46730708)
2. Chauhan BC, Garway-Heath DF, Goni FJ, Rossetti L, Bengtsson B, Viswanathan AC et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 2008; 92: 569-573. (Pubitemid 351497993)
3. Holmin C, Krakau CE. Regression analysis of the central visual field in chronic glaucoma cases. A follow-up study using automatic perimetry. Acta Ophthalmol 1982; 60: 267-274. (Pubitemid 12150604)
4. Jansonius NM. On the accuracy of measuring rates of visual field change in glaucoma. Br J Ophthalmol 2010; 94: 1404-1405.
5. Heijl A, Bengtsson B, Hyman L, Leske MC. Natural history of open-angle glaucoma. Ophthalmology 2009; 116: 2271-2276.
6. Wesselink C, Heeg GP, Jansonius NM. Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen longitudinal Glaucoma Study. Arch Ophthalmol 2009; 127: 270-274.
7. Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001; 108: 643-648.
8. Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999; 106: 2144-2153. (Pubitemid 30194238)
9. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-1279. (Pubitemid 36105431)
10. Anderson DR, Drance SM, Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology 2001; 108: 247-253. (Pubitemid 32115951)
11. McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Modelling series of visual fields to detect progression in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1995; 233: 750-755.
12. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol 1986; 101: 1-6. (Pubitemid 16128717)
13. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol 2008; 145: 343-353.
14. Wesselink C, Marcus MW, Jansonius NM. Risk factors for visual field progression in the Groningen longitudinal glaucoma study: a comparison of different statistical approaches. J Glaucoma 2011; e-pub ahead of print 22 June 2011; doi:10.1097/IJG.0b013e31822543e0.
15. Heijl A, Leske MC, Bengtsson B, Bengtsson B, Hussein M. Measuring visual field progression in the early manifest glaucoma trial. Acta Ophthalmol Scand 2003; 81: 286-293. (Pubitemid 36806269)
16. Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand 1997; 75: 184-188. (Pubitemid 27249867)
17. Brusini P. Monitoring glaucoma progression. Prog Brain Res 2008; 173: 59-73.
18. Brusini P. Clinical use of a new method for visual field damage classification in glaucoma. Eur J Ophthalmol 1996; 6: 402-407. (Pubitemid 27015942)
19. AGIS investigators. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 1994; 101: 1445-1455.
20. Hodapp E, Parrish I, Anderson DR. Clinical Decisions in Glaucoma. Mosby: St Louis, MO, 1993, pp 52-61.
21. Shin YS, Suzumura H, Furuno F, Harasawa K, Endo N, Matsuo H. Classification of glaucomatous visual field defects using the humphrey field analyzer box plots. In: Mills RP, Heijl A (eds). Perimetry Update 1990/91. Kugler Publ: Amsterdam, New York, 1991, pp 235-243.
22. Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997; 115: 777-784. (Pubitemid 27276261)
23. Lin JC, Yang MC. Correlation of visual function with health-related quality of life in glaucoma patients. J Eval Clin Pract 2010; 16: 134-140.
24. Magacho L, Lima FE, Nery AC, Sagawa A, Magacho B, Avila MP. Quality of life in glaucoma patients: regression analysis and correlation with possible modifiers. Ophthalmic Epidemiol 2004; 11: 263-270. (Pubitemid 39576618)
25. Nah YS, Seong GJ, Kim CY. Visual function and quality of life in Korean patients with glaucoma. Korean J Ophthalmol 2002; 16: 70-74.
26. van Gestel A, Webers CA, Beckers HJ, van Dongen MC, Severens JL, Hendrikse F et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond) 2010; 24: 1759-1769.
27. Wren PA, Musch DC, Janz NK, Niziol LM, Guire KE, Gillespie BW. Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle glaucoma. J Glaucoma 2009; 18: 403-411.
28. Viswanathan AC, McNaught AI, Poinoosawmy D, Fontana L, Crabb DP, Fitzke FW et al. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol 1999; 117: 450-454. (Pubitemid 29169638)
29. Akbari M, Akbari S, Pasquale LR. The association of primary open-angle glaucoma with mortality: a meta-analysis of observational studies. Arch Ophthalmol 2009; 127: 204-210.
30. Callahan D. Setting Limits: Medical Goals in an Aging Society. Simon & Schuster: New York, 1987.